Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial–Mesenchymal Transition for Tumor Metastasis Inhibition
ACS Nano · 02.06.2026 · 20 (21) · 15203-15218
DOI: 10.1021/acsnano.6c00894 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 20.05.2026. Verfasst von Qijie Diao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, …. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Autophagy, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Science and Technology Support Plan for Youth Innovation in Universities of Shandong Province of China.
Abstract (Originalsprache)
Tumor intracellular bacteria are a key driving force of epithelial-mesenchymal transition (EMT) in tumor cells, and EMT is a critical process in the metastasis cascade. Eliminating intracellular bacteria is a prospective therapeutic target for metastasis. However, existing targeted antibacterial approaches against intracellular bacteria, such as antibiotics, face challenges including drug resistance, biological barriers, or side effects. Here, we develop a tumor-targeted nanoplatform (HSO-OMDs) loaded with autophagy-induced metformin, docosahexaenoic acid, and chemotherapeutic drug oxaliplatin conjugated to hyaluronic acid, which enhances tumor cell autophagy for the effective elimination of intracellular bacteria. HSO-OMDs enhance autophagy by promoting the maturation of autophagosome, the fusion of autophagosomes and lysosomes, and the acidification of lysosomes in tumor cells. As a result, HSO-OMDs effectively eliminate intracellular bacteria by autophagy for blocking EMT processes and inhibit both primary tumor and metastasis. Collectively, our strategy against intracellular-bacteria-driven EMT by enhancing tumor cell autophagy provides a prospective approach for metastatic cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.
ORCID-Profile: Xia Zhao, Tianze Jiang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Science and Technology Support Plan for Youth Innovation in Universities of Shandong Province of China
Zitieren
APA
Diao, Q., Wang, M., Chang, T., Wang, Y., Zhang, L., Li, B., Zhao, X., & Jiang, T. (2026). Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial–Mesenchymal Transition for Tumor Metastasis Inhibition. ACS Nano, 20(21), 15203-15218. https://doi.org/10.1021/acsnano.6c00894
Vancouver
Diao Q, Wang M, Chang T, Wang Y, Zhang L, Li B, et al. Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial–Mesenchymal Transition for Tumor Metastasis Inhibition. ACS Nano. 2026;20(21):15203-15218. doi:10.1021/acsnano.6c00894
BibTeX
@article{Diao2026,
author = {Diao, Qijie and Wang, Mengya and Chang, Tianmiao and Wang, Yu and Zhang, Lianxiao and Li, Bo and Zhao, Xia and Jiang, Tianze},
title = {Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial–Mesenchymal Transition for Tumor Metastasis Inhibition},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {21},
pages = {15203--15218},
doi = {10.1021/acsnano.6c00894}
}
EUVIMED